Previous 10 |
We at White Diamond Research like shorting medical device companies with an inefficient product or products. Last year, we exposed Transenterix ( TRXC ) and Viveve Systems ( VIVE ) as each has a medical device that is fundamentally flawed. Our next medical device stock short idea is Heli...
HASBROUCK HEIGHTS, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that following the recently announced increased manufacturing capabilities, the Company has formally decided to expand its European marketing plans for Fexapotide Triflu...
Gainers : XRM +100% . XBIO +96% . YECO +69% . ABIL +66% . TSRI +33% . LGCYO +32% . ATV +31% . CADC +20% . LGCYP +18% . VLRX +17% . More news on: Xerium Technologies, Inc., Xenetic Biosciences, Inc., Yulong Eco-Materials, Stocks on the move, , Read more ....
Thinly traded micro cap Nymox Pharmaceutical ( NYMX +4.2% ) announces that it has achieved manufacturing scale-up milestones for lead drug fexapotide triflutate, increasing both batch size and yield. More news on: Nymox Pharmaceutical Corporation, Healthcare stocks news, Stocks on the ...
HASBROUCK HEIGHTS, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that manufacturing scale-up milestones have been reached for the Company's lead compound Fexapotide Triflutate (FT). Over the past year, the Company has worked...
News, Short Squeeze, Breakout and More Instantly...
Nymox Pharmaceutical Corporation Company Name:
NYMX Stock Symbol:
NASDAQ Market:
Nymox Pharmaceutical Corporation Website:
IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq,...
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a mid-2nd quarter update on ongoing activities. The Company reported last month that it expects to submit an additional new submission for marketing...
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a current update on the Company's ongoing projects. The Company recently submitted its application for Marketing Authorization Application to the ...